ScholarLens Back to search
2018•ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENTRequires access

ANALYSIS OF THE EFFECTIVENESS OF THE IMPLEMENTATION OF THE PILOT PROJECT OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN RISK GROUPS IN THE MUNICIPALITIES LEADING ON INDICATORS OF MORTALITY FROM COMMUNITY-ACQUIRED PNEUMONIA

И. И. Козлова, Е. И. Сисин, Н. А. Остапенко, О. А. Ежова, Н. Г. Кашапов

Open publisher page 2 citations

Abstract

There were established municipalities with the highest mortality rates from community-acquired pneumonia (CAP). When etiological deciphering of CAP confirmed the role of S. pneumoniae (Klein) Chester in the development and outcome of this disease. Among the risk contingents were vaccinated against pneumococcal disease, which had an impact on morbidity and mortality from CAP. It is proved that the vaccination of contingent risk against pneumococcal disease reduces the morbidity and mortality from CAP.

About this research paper

What this paper is about

There were established municipalities with the highest mortality rates from community-acquired pneumonia (CAP). When etiological deciphering of CAP confirmed the role of S. pneumoniae (Klein) Chester in the development and outcome of this disease. Among the risk contingents were vaccinated against pneumococcal disease, which had an impact on morbidity and mortality from CAP. It is proved that the vaccination of contingent risk against pneumococcal disease reduces the morbidity and mortality from CAP.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

There were established municipalities with the highest mortality rates from community-acquired pneumonia (CAP). When etiological deciphering of CAP confirmed the role of S. pneumoniae (Klein) Chester in the development and outcome of this disease. Among the risk contingents were vaccinated against pneumococcal disease, which had an impact on morbidity and mortality from CAP. It is proved that the vaccination of contingent risk against pneumococcal disease reduces the morbidity and mortality from CAP.

Key concepts: Community-acquired pneumonia, Pneumococcal pneumonia, Pneumonia, Pneumococcal disease, Vaccination, Streptococcus pneumoniae, Medicine, Etiology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
ANALYSIS OF THE EFFECTIVENESS OF THE IMPLEMENTATION OF THE PILOT PROJECT OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN RISK GROUPS IN THE MUNICIPALITIES LEADING ON INDICATORS OF MORTALITY FROM COMMUNITY-ACQUIRED PNEUMONIA — Research Paper | ScholarLens